Cite
HARVARD Citation
Porter, D. et al. (2016). Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study*. HIV clinical trials. 17 (1), pp. 29-37. [Online].